Atorvastatin, an HMG-CoA reductase inhibitor and effective lipid-regulating agent. Part II. Synthesis of side-chain-labeled [C-14]atorvastatin.

Authors
Citation
Ht. Lee et Pwk. Woo, Atorvastatin, an HMG-CoA reductase inhibitor and effective lipid-regulating agent. Part II. Synthesis of side-chain-labeled [C-14]atorvastatin., J LABEL C R, 42(2), 1999, pp. 129-133
Citations number
7
Categorie Soggetti
Chemistry & Analysis","Inorganic & Nuclear Chemistry
Journal title
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
ISSN journal
03624803 → ACNP
Volume
42
Issue
2
Year of publication
1999
Pages
129 - 133
Database
ISI
SICI code
0362-4803(199902)42:2<129:AAHRIA>2.0.ZU;2-T
Abstract
[C-14]Atorvastatin was synthesized in a ten-step sequence with an overall y ield of 5.7%. The label was introduced as sodium [1-C-14]acetate, which was converted via the acid chloride to the (S)-2-hydroxy-1,2,2-triphenylethyl ester 4. Chiral condensation of 4 with aldehyde 5 gave the chiral ester int ermediate 6 with a yield of about 70%. Following transesterification of 6 t o a methyl ester and condensation with tert-butyl lithioacetate to give (R) -beta-ketoester S, a second chiral center was generated by reduction of the hydroxyketone 8, giving the (R,R)-dihydroxy ester 9, which was then conver ted via the acid to the lactone 11. The desired pure diastereomer 11, obtai ned from the mother liquor during crystallization, was then converted to th e corresponding calcium salt (2:1) 13 (atorvastatin).